Endocrinology, Diabetes & Metabolism Doctors in Florence, MA - Medicare Status, Address, Contact

1 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 1

Dr. Peter William Butler, M.D.
Internal Medicine - Endocrinology, Diabetes & Metabolism
Medicare: Not Enrolled in Medicare
Practice Location: 15 Straw Ave, Suite 116, Brown Area, Florence, MA 01062
Phone: 413-582-0011 Fax: 413-582-0099

News Archive

AF Association survey shows impact of AF diagnosis on patients

Atrial Fibrillation (AF) Aware Week aims to raise awareness of an important, yet not well understood heart rhythm disturbance. Taking place from the 23-29 November AF Aware Week increases awareness and understanding of AF amongst the general public. With AF effecting over a million people in the UK it is important that understanding of this condition is improved.

Pre-exposure prophylaxis reduces risk of HIV infection

In a result that will fundamentally change approaches to HIV prevention in Africa, an international study has demonstrated that individuals at high risk for HIV infection who took a daily tablet containing an HIV medication - either the antiretroviral medication tenofovir or tenofovir in combination with emtricitabine - experienced significantly fewer HIV infections than those who received a placebo pill.

Studies identify a more rapid method to decontaminate N95 masks

Two Rutgers-led studies have identified a more rapid method to decontaminate N95 masks using vaporized hydrogen peroxide – making reuse of masks more economically feasible and practical for health care workers on the frontlines against COVID-19.

Comparison of processability of medical resins reveals effect of physical properties on moldability

Both physical properties and processability play key roles when injection-molded parts are mass produced. When producing medical parts, a consistent, high degree of accuracy is also vital. It is relatively simple to adjust a process to account for differences in molecular weight once that process is optimized for a specific polymer. It is much more complex to adjust the process for changes in polymers.

FDA approves Takeda's NESINA, OSENI and KAZANO for treatment of type 2 diabetes

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved NESINA (alogliptin) and the fixed-dose combination (FDC) therapies OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl) for the treatment of type 2 diabetes in adults as adjuncts to diet and exercise.

Endocrinology, Diabetes & Metabolism Doctors in Florence, MA Accepting Medicare